Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NOVTU vs ABSI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABSI Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 6–2 Matrix Metrics)

ABSI Overall Winner 6-Pillar Tally: NOVTU 0 – 4 ABSI (2 Tie) Matrix Metrics: NOVTU 2 – 6 ABSI

As of Nov 16, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over NOVTU (NOVTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NOVTU carries a Unified Composite Score of 42.5/100 (HOLD) at $50.76 (N/M Forward P/E, N/A operating margin), whereas ABSI carries 37.5/100 (SELL) at $7.72 (N/M Forward P/E, -9108.3% operating margin).

  • Composite vs. Pillar Nuance: While NOVTU currently prints a higher short-term Unified Composite Score (42.5/100 HOLD vs. ABSI 37.5/100 SELL), ABSI captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-9108.3% vs. N/A operating margin) and revenue trajectory (-19.6% vs. N/A YoY).
  • Technical & Structure Timing Caution: NOVTU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1); meanwhile ABSI is in a Breakdown options structure phase (RSI 39.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NOVTU vs ABSI
NOVTU US Equity
NOVTU
Institutional Equity
$50.76
-1.05% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.70β · 65% Vol
Unified Composite Score
42.5 / 100 HOLD
Tech 30.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 33
RSI-14: 33.1 · SMA20: $58.29 · SMA50: $59.48
ABSI NASDAQ Head-to-Head Winner
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.72
-8.58% 1D
Market Cap $1.6B
TTM Revenue $1.5M
Forward P/E N/M
Beta / 30D Vol 3.31β · 126% Vol
Unified Composite Score
37.5 / 100 SELL
Tech 27.0 Fund 51.0 Flow 71.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.3 · SMA20: $9.94 · SMA50: $9.63

6-Pillar Scorecard Institutional Category Breakdown (NOVTU 0 – 4 ABSI)

Columns: Metric · NOVTU · ABSI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale ABSI
Revenue Growth (YoY) N/A -19.6%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $1.5M
Market Cap N/A $1.6B
3. Profitability & Quality ABSI
Gross Margin N/A N/A
Operating Margin N/A -9108.3%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -58.6%
4. Balance Sheet & Cash Flow ABSI
Cash Generation (TTM) N/A -$112M
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $10M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABSI
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 169.1% (15th %ile)
Put/Call OI Skew N/A 0.57x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NOVTU (2) vs ABSI (6)
Institutional Metric NOVTU ABSI Criterion Row Edge
Market Capitalization
Scale
N/A $1.6B Larger Scale ABSI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A -19.6% Higher Growth ABSI
Operating Margin (TTM)
Profitability
N/A -9108.3% Higher Margin ABSI
Net Profit Margin
Profitability
N/A 0.0% Higher Margin ABSI
Return on Equity (ROE)
Capital Efficiency
N/A -58.6% Higher ROE ABSI
52-Week Range Position
Momentum
11% ($48–$77) 53% ($2–$13) Stronger Trend ABSI
Beta / 30D Volatility
Risk Regime
1.70β · 65% Vol 3.31β · 126% Vol Lower Realized Risk NOVTU
Unified Institutional Score
Composite Signal
42.5 / 100 (HOLD) 37.5 / 100 (SELL) Higher Composite NOVTU
Trailing 12M Revenue (USD)
Operating Scale
N/A $1.5M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$112M ($10M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABSI +2.85 pp
NOVTU: -9.21% · ABSI: -6.36%
3M Horizon ABSI +10.63 pp
NOVTU: -27.03% · ABSI: -16.4%
6M Horizon ABSI +63.03 pp
NOVTU: -23.59% · ABSI: +39.44%
1Y Horizon ABSI +193.1 pp
NOVTU: -0.49% · ABSI: +192.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NOVTU vs ABSI. Trailing 12-month operating profitability (NOVTU N/A vs ABSI -9108.3%) and valuation multiples (NOVTU N/M vs ABSI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NOVTU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
ABSI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.5M
Gross MarginN/A
Op. Margin-9108.3%
ROE / Fwd P/E-58.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NOVTU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NOVTU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
97d in phase · OBV NEUTRAL
Current IV 169.1%
IV Percentile 15th %ile
Put/Call OI Skew 0.57x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NOVTU Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABSI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.6B market capitalization and -9108.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NOVTU vs ABSI Key Questions & Quantitative Answers

As of Nov 16, 2026, Absci Corporation (ABSI) is the stronger overall head-to-head candidate over NOVTU (NOVTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NOVTU carries a Unified Composite Score of 42.5/100 (HOLD) at $50.76 (N/M Forward P/E, N/A operating margin), whereas ABSI carries 37.5/100 (SELL) at $7.72 (N/M Forward P/E, -9108.3% operating margin). Composite vs. Pillar Nuance: While NOVTU currently prints a higher short-term Unified Composite Score (42.5/100 HOLD vs. ABSI 37.5/100 SELL), ABSI captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-9108.3% vs. N/A operating margin) and revenue trajectory (-19.6% vs. N/A YoY). Technical & Structure Timing Caution: NOVTU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1); meanwhile ABSI is in a Breakdown options structure phase (RSI 39.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABSI leads the Growth & Scale pillar: NOVTU posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ABSI at -19.6% YoY revenue growth and +0.0% YoY earnings growth on $1.5M TTM revenue (N/A gross margin, -9108.3% operating margin). On trailing 12-month operating scale, NOVTU generates N/A in USD-normalized revenue versus $1.5M for ABSI. In operating R&D and SG&A reinvestment, NOVTU deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABSI.

NOVTU and ABSI trade at balanced relative valuation multiples. NOVTU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABSI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NOVTU (N/A ROE) versus ABSI (-58.6% ROE) capital efficiency.

In options market volatility and institutional positioning, NOVTU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.70β · 65% Vol realized risk). By comparison, ABSI carries 169.1% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.57x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.31β · 126% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.